Is gout more common in the hands compared to pseudogout (calcium pyrophosphate deposition disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Gout is less common in the hands compared to pseudogout. While gout typically affects the big toe (podagra) and other lower extremity joints like ankles and knees, pseudogout more frequently targets larger joints such as knees, wrists, and hands, particularly the triangular fibrocartilage of the wrist. When gout does affect the hands, it tends to involve the distal interphalangeal joints and has an asymmetric distribution, whereas pseudogout often affects the metacarpophalangeal joints and wrist with a more symmetric pattern. The underlying mechanisms differ significantly: gout results from monosodium urate crystal deposition due to hyperuricemia, while pseudogout (calcium pyrophosphate deposition disease) involves calcium pyrophosphate crystal formation, often associated with aging, metabolic disorders, or genetic factors. Some key points to consider:

  • Distinguishing between these conditions requires joint fluid analysis, as gout crystals appear needle-shaped and negatively birefringent under polarized light, while pseudogout crystals are rhomboid-shaped and weakly positively birefringent 1.
  • This distinction is crucial for proper treatment, as gout management focuses on urate-lowering therapy while pseudogout treatment targets inflammation control.
  • The most recent and highest quality study on the topic of gout and pseudogout is from 2021, which provides an update on the diagnosis and treatment of these conditions 2.
  • Other studies have also investigated the use of non-steroidal anti-inflammatory drugs (NSAIDs) for acute gout, with moderate-quality evidence suggesting that NSAIDs and COXIBs produce similar benefits in terms of pain, swelling, and global improvement, but COXIBs are associated with fewer adverse events 2, 3.
  • However, the question of whether gout is common in hands vs pseudo gout is best answered by considering the typical joints affected by each condition, rather than the specific treatments used.
  • In terms of morbidity, mortality, and quality of life, it is essential to accurately diagnose and treat gout and pseudogout to prevent long-term joint damage and improve patient outcomes.
  • Based on the available evidence, the most appropriate approach is to prioritize joint fluid analysis and crystal identification to distinguish between gout and pseudogout, and to tailor treatment accordingly.

References

Research

Non-steroidal anti-inflammatory drugs for acute gout.

The Cochrane database of systematic reviews, 2021

Research

Non-steroidal anti-inflammatory drugs for acute gout.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.